Skip to main content
. 2019 Mar 28;34(1):838–852. doi: 10.1080/14756366.2019.1593160

Figure 4.

Figure 4.

Graphical representation of IC50 expressed in µM of test compounds against MCF-7 cell line compared to doxorubicin and erlotinib.